Search Thermo Fisher Scientific
- Order Status
- Quick Order
-
Don't have an account ? Create Account
LentiArray and LentiPool CRISPR Libraries
Arrayed or pooled lentiviral libraries. Expanded capabilities. New discoveries.
Award-winning Invitrogen LentiArray and LentiPool CRISPR Libraries support the application of CRISPR-Cas9 technology in functional genomics screening. LentiArray CRISPR formats are delivered in an arrayed format compatible with high-throughput screening platforms and provide a flexible system that doesn’t impose limitations on your functional genomics assay design or research goals.
LentiPool CRISPR Libraries empower CRISPR-Cas9 screening without the need for high-throughput infrastructure. These high quality pooled lentiviral collections have undergone extensive quality assurance and are delivered as high-titer particles for a gene knockout screen with maximum impact.
Features of the Invitrogen Lentiviral CRISPR Libraries
- Advanced gRNA designs for maximum knockout efficiency without sacrificing specificity
- Up to four high quality gRNAs per gene target for efficient knockout in a wide variety of cell types
- Delivered as high titer, ready-to-use lentivirus or as glycerol stocks
- Complete set of controls and lentiviruses against single gene targets available to support pre-screen assay development and to perform rapid post screen hit validation
- Defined libraries (19) and custom options available allowing you to focus on defined gene sets or perform unbiased whole genome surveys.
LentiArray CRISPR Libraries
- Arrayed pools of at least four high-quality gRNAs per gene target
- Delivered as one-gene-per-well pools for efficient knockout in a wide variety of cell types
- Available as high-titer, ready-to-use lentiviral particles or glycerol stocks
- Custom or pre-defined gene collections
Application Note: Powerful loss-of-function screening with LentiArray CRISPR gRNAs
A demonstration of Invitrogen LentiArray CRISPR guide RNA reagents being utilized to maximize functional target gene knockout while maintaining target specificity
LentiPool CRISPR Libraries
- Four high-quality gRNAs per gene target in pools for screening without complex automation
- Delivered as ready-to-use lentiviral pools at high titer: >1 x 108 TU/mL
- Rigorous QC process includes sequencing to confirm gRNA representation
- Many libraries are on the shelf and ready to ship!
Application Note: A positive-selection screen for a 6-thioguanine resistance gene using the LentiPool lentiviral negative control CRISPR library spiked with HPRT1 gRNAs
A demonstration of a positive selection screen using 6-thioguanine (6-TG) treatment as a selective pressure to demonstrate the power of the pooled screening approach
The LentiPool and LentiArray library collections provides all the tools you need to expand your screening capabilities with CRISPR-Cas9 technology including LentiArray Cas9 lentivirus, LentiArray controls, and individual LentiArray gRNAs. Explore the complete CRISPR library portfolio and find out how you can apply the power of CRISPR-Cas9 technology to your screening efforts and make your next big discovery whether using the LentiArray or LentiPool formats.
Available CRISPR library collections
The Invitrogen LentiArray CRISPR Human Whole Genome Library is ideal for whole genome surveys to identify novel targets in biological pathways and disease development. The gene targets within the LentiArray CRISPR Human Whole Genome Library were selected using the most up-to-date genome databases, including the NCBI RefSeq database, and cross-referenced to the Gene Ontology Consortium (GO) database and/or the HUGO Gene Nomenclature Committee (HGNC). The gRNA designs for each target were then created using a proprietary design algorithm developed by the scientists at Thermo Fisher Scientific. The LentiArray CRISPR Human Whole Genome Library targets 18,392 genes with up to four gRNAs per gene target (pooled in a single well), for a total of 73,568 gRNAs. Libraries are delivered as 100 μL of ready-to-use lentiviral particles per gene target with an average titer of 1X108 TU/ml and are also available as glycerol stocks. Libraries are supplied in 96-well plates.
The Invitrogen LentiPool CRISPR library has the same gene coverage and is supplied as lentiviral pools containing four gRNAs per gene, delivered as ready-to-use lentivirus at high titer: >1 x 108 TU/mL.
The Invitrogen LentiArray CRISPR Human Druggable Genome Library is ideal for identifying potentially therapeutics targets involved in the development and progression of disease. The gene targets within the LentiArray CRISPR Human Druggable Genome Library were selected using the most up-to-date genome databases, including the NCBI RefSeq database, and cross-referenced to the Gene Ontology Consortium (GO) database and/or the HUGO Gene Nomenclature Committee (HGNC). The gRNA designs for each target were then created using a proprietary design algorithm developed by the scientists at Thermo Fisher Scientific. The LentiArray CRISPR Human Druggable Genome Library targets 10,132 genes with up to four gRNAs per gene target (pooled in a single well), for a total of 40,512 gRNAs. Libraries are delivered as 100 μL of ready-to-use lentiviral particles per gene target with an average titer of 1X108 TU/ml and are also available as glycerol stocks. Libraries are supplied in 96-well plates.
The Invitrogen LentiPool CRISPR library has the same gene coverage and is supplied as lentiviral pools containing four gRNAs per gene, delivered as ready-to-use lentivirus at high titer: >1 x 108 TU/mL.
Kinases are involved in the majority of signaling cascades, and dysregulation of kinase activity is linked to development of numerous diseases, making kinases a key class of drug targets. The gene targets within the Invitrogen LentiArray CRISPR Human Kinase Library were selected using the most up-to-date genome databases, including the NCBI RefSeq database, and cross-referenced to the Gene Ontology Consortium (GO) database and/or the HUGO Gene Nomenclature Committee (HGNC) as well as additional resources such as the KinBase database. The gRNA designs for each target were then created using a proprietary design algorithm developed by the scientists at Thermo Fisher Scientific. The LentiArray CRISPR Human Kinase Library targets 822 genes with up to four gRNAs per gene target (pooled in a single well), for a total of 3,288 gRNAs. Libraries are delivered as 100 μL of ready-to-use lentiviral particles per gene target with an average titer of 1X108 TU/ml and are also available as glycerol stocks. Libraries are supplied in 96-well plates.
The Invitrogen LentiPool CRISPR library has the same gene coverage and is supplied as lentiviral pools containing four gRNAs per gene, delivered as ready-to-use lentivirus at high titer: >1 x 108 TU/mL.
G protein–coupled receptors (GPCRs) are regulators of a wide range of physiological and disease processes. GPCRs have emerged as one of the most druggable classes of genes, with nearly 30% of FDA-approved drugs targeting GPCRs. The gene targets within the Invitrogen LentiArray CRISPR Human GPCR Library were selected using the most up-to-date genome databases, including the NCBI RefSeq database, and cross-referenced to the Gene Ontology Consortium (GO) database and/or the HUGO Gene Nomenclature Committee (HGNC). The gRNA designs for each target were then created using a proprietary design algorithm developed by the scientists at Thermo Fisher Scientific. The LentiArray CRISPR Human GPCR Library targets 446 genes with up to four gRNAs per gene target (pooled in a single well), for a total of 1,784 gRNAs. Libraries are delivered as 100 μL of ready-to-use lentiviral particles per gene target with an average titer of 1X108 TU/ml and are also available as glycerol stocks. Libraries are supplied in 96-well plates.
The Invitrogen LentiPool CRISPR library has the same gene coverage and is supplied as lentiviral pools containing four gRNAs per gene, delivered as ready-to-use lentivirus at high titer: >1 x 108 TU/mL.
The Invitrogen LentiArray CRISPR Human Cancer Biology Library is a collection that targets some of the most common genes involved in the development of cancer. The gene targets within the LentiArray CRISPR Human Cancer Biology Library were selected using the most up-to-date genome databases, including the NCBI RefSeq database, and cross-referenced to the Gene Ontology Consortium (GO) database and/or the HUGO Gene Nomenclature Committee (HGNC) as well as The Cancer Genome Atlas (TCGA). The gRNA designs for each target were then created using a proprietary design algorithm developed by the scientists at Thermo Fisher Scientific. The LentiArray CRISPR Human Cancer Biology Library targets 510 genes with up to four gRNAs per gene target (pooled in a single well), for a total of 2,040 gRNAs. Libraries are delivered as 100 μL of ready-to-use lentiviral particles per gene target with an average titer of 1X108 TU/ml and are also available as glycerol stocks. Libraries are supplied in 96-well plates.
The Invitrogen LentiPool CRISPR library has the same gene coverage and is supplied as lentiviral pools containing four gRNAs per gene, delivered as ready-to-use lentivirus at high titer: >1 x 108 TU/mL.
Epigenetic regulation of gene expression plays a central role in normal development and is being recognized as a contributing factor to the development of many diseases. The gene targets within the Invitrogen LentiArray CRISPR Human Epigenetics Library were selected using the most up-to-date genome databases, including the NCBI RefSeq database, and cross-referenced to the Gene Ontology Consortium (GO) database and/or the HUGO Gene Nomenclature Committee (HGNC). The gRNA designs for each target were then created using a proprietary gRNA design algorithm developed by the scientists at Thermo Fisher Scientific. The LentiArray CRISPR Human Epigenetics Library targets 396 genes with up to four gRNAs per gene target (pooled in a single well), for a total of 1,548 gRNAs. Libraries are delivered as 100 μL of ready-to-use lentiviral particles per gene target with an average titer of 1X108 TU/ml and are also available as glycerol stocks. Libraries are supplied in 96-well plates.
The Invitrogen LentiPool CRISPR library has the same gene coverage and is supplied as lentiviral pools containing four gRNAs per gene, delivered as ready-to-use lentivirus at high titer: >1 x 108 TU/mL.
The ubiquitin system is integral to maintaining cellular homeostasis by regulating protein turnover. Dysregulation of the ubiquitin system has been linked to multiple diseases including cancer and neurodegenerative, musculoskeletal, cardiovascular, and metabolic diseases, as well as being linked to viral infection. The gene targets within the Invitrogen™ LentiArray™ CRISPR Human Ubiquitin Library were selected using the most up-to-date genome databases, including the NCBI RefSeq database, and cross-referenced to the Gene Ontology Consortium (GO) database and/or the HUGO Gene Nomenclature Committee (HGNC). The gRNA designs for each target were then created using a proprietary gRNA design algorithm developed by the scientists at Thermo Fisher Scientific. The LentiArray CRISPR Human Ubiquitin Library targets 943 genes with up to four gRNAs per gene target (pooled in a single well), for a total of 3,722 gRNAs. Libraries are delivered as 100 μL of ready-to-use lentiviral particles per gene target with an average titer of 1X108 TU/ml and are also available as glycerol stocks. Libraries are supplied in 96-well plates.
The Invitrogen LentiPool CRISPR library has the same gene coverage and is supplied as lentiviral pools containing four gRNAs per gene, delivered as ready-to-use lentivirus at high titer: >1 x 108 TU/mL.
Cell cycle regulators are important to normal development and also play a role in the development of cancer and cardiovascular, inflammatory, and neurodegenerative diseases. The gene targets within the Invitrogen LentiArray CRISPR Human Cell Cycle Library were selected using the most up-to-date genome databases, including the NCBI RefSeq database, and cross-referenced to the Gene Ontology Consortium (GO) database and/or the HUGO Gene Nomenclature Committee (HGNC). The targets include cyclin-dependent kinases, or CDKs, which are crucial for cell cycle progression; regulators of cell cycle progression such as CIP/KIP family proteins and members of the INK4 family of cell cycle inhibitors; proteins in the retinoblastoma family; and DNA replication factors such as the cell division cycle proteins (CDCs). The gRNA designs for each target were then created using a proprietary gRNA design algorithm developed by the scientists at Thermo Fisher Scientific. The LentiArray CRISPR Human Cell Cycle Library targets 1,444 genes with up to four gRNAs per gene target (pooled in a single well), for a total of 5,776 gRNAs. Libraries are delivered as 100 μL of ready-to-use lentiviral particles per gene target with an average titer of 1X108 TU/ml and are also available as glycerol stocks. Libraries are supplied in 96-well plates.
The Invitrogen LentiPool CRISPR library has the same gene coverage and is supplied as lentiviral pools containing four gRNAs per gene, delivered as ready-to-use lentivirus at high titer: >1 x 108 TU/mL.
Membrane trafficking proteins are involved in a number of processes, including neurotransmitter and endocrine release, phagocytosis, endocytosis, and autophagy. The gene targets within the Invitrogen LentiArray CRISPR Human Membrane Trafficking Library were selected using the most up-to-date genome databases, including the NCBI RefSeq database, and cross-referenced to the Gene Ontology Consortium (GO) database and/or the HUGO Gene Nomenclature Committee (HGNC). The
The Invitrogen LentiPool CRISPR library has the same gene coverage and is supplied as lentiviral pools containing four gRNAs per gene, delivered as ready-to-use lentivirus at high titer: >1 x 108 TU/mL.
Transcription factors are key regulators of gene expression. The gene targets within the Invitrogen LentiArray CRISPR Human Transcription Factor Library were selected using the most up-to-date genome databases, including the NCBI RefSeq database, and cross-referenced to the Gene Ontology Consortium (GO) database and/or the HUGO Gene Nomenclature Committee (HGNC). The gRNA designs for each target were then created using a proprietary gRNA design algorithm developed by the scientists at Thermo Fisher Scientific. The LentiArray CRISPR Human Transcription Factor Library targets 1,931 genes with up to four gRNAs per gene target (pooled in a single well), for a total of 7,724 gRNAs. Libraries are delivered as 100 μL of ready-to-use lentiviral particles per gene target with an average titer of 1X108 TU/ml and are also available as glycerol stocks. Libraries are supplied in 96-well plates.
The Invitrogen LentiPool CRISPR library has the same gene coverage and is supplied as lentiviral pools containing four gRNAs per gene, delivered as ready-to-use lentivirus at high titer: >1 x 108 TU/mL.
Nuclear hormone receptors are a family of transcription factors that are activated by lipid-soluble ligands such as steroid hormones, thyroid hormone, vitamin D, and retinoic acid. Nuclear hormone receptors regulate a range of biological processes, including metabolism, development, proliferation, and reproduction. The gene targets within the Invitrogen LentiArray CRISPR Human Nuclear Hormone Receptor Library were selected using the most up-to-date genome databases, including the NCBI RefSeq database, and cross-referenced to the Gene Ontology Consortium (GO) database and/or the HUGO Gene Nomenclature Committee (HGNC). The gRNA designs for each target were then created using a proprietary gRNA design algorithm developed by the scientists at Thermo Fisher Scientific. The LentiArray CRISPR Human Nuclear Hormone Receptor Library targets 47 genes with up to four gRNAs per gene target (pooled in a single well), for a total of 188 gRNAs. Libraries are delivered as 100 μL of ready-to-use lentiviral particles per gene target with an average titer of 1X108 TU/ml and are also available as glycerol stocks. Libraries are supplied in 96-well plates.
The Invitrogen LentiPool CRISPR library has the same gene coverage and is supplied as lentiviral pools containing four gRNAs per gene, delivered as ready-to-use lentivirus at high titer: >1 x 108 TU/mL.
Apoptosis is a tightly regulated process that is essential for maintaining homeostasis in multicellular organisms. Inhibition of apoptosis can result in the development of cancer, autoimmune, and inflammatory diseases and is also involved in viral infection. Conversely, overactivation of apoptosis can lead to atrophy, tissue damage, and neurodegenerative disease. The gene targets within the Invitrogen LentiArray CRISPR Human Apoptosis Library were selected using the most up-to-date genome databases, including the NCBI RefSeq database, and cross-referenced to the Gene Ontology Consortium (GO) database and/or the HUGO Gene Nomenclature Committee (HGNC). The gRNA designs for each target were then created using a proprietary gRNA design algorithm developed by the scientists at Thermo Fisher Scientific. The LentiArray CRISPR Human Apoptosis Library targets 904 genes with up to four gRNAs per gene target (pooled in a single well), for a total of 3,616 gRNAs. Libraries are delivered as 100 μL of ready-to-use lentiviral particles per gene target with an average titer of 1X108 TU/ml and are also available as glycerol stocks. Libraries are supplied in 96-well plates.
The Invitrogen LentiPool CRISPR library has the same gene coverage and is supplied as lentiviral pools containing four gRNAs per gene, delivered as ready-to-use lentivirus at high titer: >1 x 108 TU/mL.
Transporter proteins play a key role in pharmacology, affecting how molecules are moved across cellular membranes. The gene targets within the Invitrogen LentiArray CRISPR Human Drug Transport Library were selected using the most up-to-date genome databases, including the NCBI RefSeq database, and cross-referenced to the Gene Ontology Consortium (GO) database and/or the HUGO Gene Nomenclature Committee (HGNC). The gRNA designs for each target were then created using a proprietary gRNA design algorithm developed by the scientists at Thermo Fisher Scientific. The LentiArray CRISPR Human Nuclear Hormone Receptor Library targets 98 genes with up to four gRNAs per gene target (pooled in a single well), for a total of 392 gRNAs. Libraries are delivered as 100 μL of ready-to-use lentiviral particles per gene target with an average titer of 1X108 TU/ml and are also available as glycerol stocks. Libraries are supplied in 96-well plates.
The Invitrogen LentiPool CRISPR library has the same gene coverage and is supplied as lentiviral pools containing four gRNAs per gene, delivered as ready-to-use lentivirus at high titer: >1 x 108 TU/mL.
Ion channels are integral membrane proteins that establish the electrochemical gradient that gives rise to both the resting membrane potential and the formation of action potentials which are crucial to nerve conduction and heart and muscle contraction, as well as other processes such as insulin release from the pancreas and activation of T cells. The gene targets within the Invitrogen LentiArray CRISPR Human Ion Channel Library were selected using the most up-to-date genome databases, including the NCBI RefSeq database, and cross-referenced to the Gene Ontology Consortium (GO) database and/or the HUGO Gene Nomenclature Committee (HGNC). The gRNA designs for each target were then created using a proprietary gRNA design algorithm developed by the scientists at Thermo Fisher Scientific. The LentiArray CRISPR Human Ion Channel Library targets 328 genes with up to four gRNAs per gene target (pooled in a single well), for a total of 1,312 gRNAs. Libraries are delivered as 100 μL of ready-to-use lentiviral particles per gene target with an average titer of 1X108 TU/ml and are also available as glycerol stocks. Libraries are supplied in 96-well plates.
The Invitrogen LentiPool CRISPR library has the same gene coverage and is supplied as lentiviral pools containing four gRNAs per gene, delivered as ready-to-use lentivirus at high titer: >1 x 108 TU/mL.
The broad array of cell surface proteins allows cells to receive information from, and react to, their environment. The gene targets within the Invitrogen LentiArray CRISPR Human Cell Surface Protein Library were selected using the most up-to-date genome databases, including the NCBI RefSeq database, and cross-referenced to the Gene Ontology Consortium (GO) database and/or the HUGO Gene Nomenclature Committee (HGNC). The gRNA designs for each target were then created using a proprietary gRNA design algorithm developed by the scientists at Thermo Fisher Scientific. The LentiArray CRISPR Human Cell Surface Protein Library targets 778 genes with up to four gRNAs per gene target (pooled in a single well), for a total of 3,112 gRNAs. Libraries are delivered as 100 μL of ready-to-use lentiviral particles per gene target with an average titer of 1X108 TU/ml and are also available as glycerol stocks. Libraries are supplied in 96-well plates.
The Invitrogen LentiPool CRISPR library has the same gene coverage and is supplied as lentiviral pools containing four gRNAs per gene, delivered as ready-to-use lentivirus at high titer: >1 x 108 TU/mL.
Proteases degrade proteins but are also integral signaling molecules, and the dysregulation of protease signaling pathways has been implicated in the development of cardiovascular disease, neurological disorders, cancer, and inflammatory disease. The gene targets within the Invitrogen™ LentiArray™ CRISPR Human Protease Library were selected using the most up-to-date genome databases, including the NCBI RefSeq database, and cross-referenced to the Gene Ontology Consortium (GO) database and/or the HUGO Gene Nomenclature Committee (HGNC). The gRNA designs for each target were then created using a proprietary gRNA design algorithm developed by the scientists at Thermo Fisher Scientific. The LentiArray CRISPR Human Protease Library targets 475 genes with up to four gRNAs per gene target (pooled in a single well), for a total of 1,900 gRNAs. Libraries are delivered as 100 μL of ready-to-use lentiviral particles per gene target with an average titer of 1X108 TU/ml and are also available as glycerol stocks. Libraries are supplied in 96-well plates.
The Invitrogen LentiPool CRISPR library has the same gene coverage and is supplied as lentiviral pools containing four gRNAs per gene, delivered as ready-to-use lentivirus at high titer: >1 x 108 TU/mL.
Tumor suppressors are negative regulators of cell cycle progression, and loss or mutation of tumor suppressor genes is often involved in the development of cancer. The gene targets within the Invitrogen LentiArray CRISPR Human Tumor Suppressor Library were selected using the most up-to-date genome databases, including the NCBI RefSeq database, and cross-referenced to the Gene Ontology Consortium (GO) database and/or the HUGO Gene Nomenclature Committee (HGNC) as well as the Tumor Suppressor Gene Database (TSGene). The gRNA designs for each target were then created using a proprietary gRNA design algorithm developed by the scientists at Thermo Fisher Scientific. The LentiArray CRISPR Human Tumor Suppressor Library targets 716 genes with up to four gRNAs per gene target (pooled in a single well), for a total of 2,864 gRNAs. Libraries are delivered as 100 μL of ready-to-use lentiviral particles per gene target with an average titer of 1X108 TU/ml and are also available as glycerol stocks. Libraries are supplied in 96-well plates.
The Invitrogen LentiPool CRISPR library has the same gene coverage and is supplied as lentiviral pools containing four gRNAs per gene, delivered as ready-to-use lentivirus at high titer: >1 x 108 TU/mL.
DNA surveillance proteins continuously monitor DNA integrity and activate cell cycle checkpoints and DNA repair pathways in response to DNA damage. The gene targets within the Invitrogen LentiArray CRISPR Human DNA Damage Response Library were selected using the most up-to-date genome databases, including the NCBI RefSeq database, and cross-referenced to the Gene Ontology Consortium (GO) database and/or the HUGO Gene Nomenclature Committee (HGNC). The
The Invitrogen LentiPool CRISPR library has the same gene coverage and is supplied as lentiviral pools containing four gRNAs per gene, delivered as ready-to-use lentivirus at high titer: >1 x 108 TU/mL.
Reversible phosphorylation is a central regulatory process in signal transduction pathways. Phosphatases dephosphorylate their target proteins, are integral to the regulation of the signaling pathways, and are increasingly being analyzed as potential therapeutic targets. The gene targets within the Invitrogen LentiArray Human Phosphatase CRISPR Library were selected using the most up-to-date genome databases, including the NCBI RefSeq database, and cross-referenced to the Gene Ontology Consortium (GO) database and/or the HUGO Gene Nomenclature Committee (HGNC). The gRNA designs for each target were then created using a proprietary gRNA design algorithm developed by the scientists at Thermo Fisher Scientific. The LentiArray CRISPR Human Phosphatase Library targets 288 genes with up to four gRNAs per gene target (pooled in a single well), for a total of 1,152 gRNAs. Libraries are delivered as 100 μL of ready-to-use lentiviral particles per gene target with an average titer of 1X108 TU/ml and are also available as glycerol stocks. Libraries are supplied in 96-well plates.
The Invitrogen LentiPool CRISPR library has the same gene coverage and is supplied as lentiviral pools containing four gRNAs per gene, delivered as ready-to-use lentivirus at high titer: >1 x 108 TU/mL.
Order now:
High quality controls play an integral role in the successful development and performance of high throughput screens. Don't forget to get your controls to help you optimize delivery conditions, maximize editing efficiency and establish hit selection criteria.
Ordering information
Contact us if you would like more information or pricing on the libraries listed in any of the available LentiArray or LentiPool formats.
| CRISPR Library | LentiArray Lentiviral particles, Cat. No. | LentiArray glycerol stocks, Cat. No. | LentiPool ordering | Gene count |
|---|---|---|---|---|
| Kinase CRISPR Library | A42234 | A32167 | Inquire | 822 |
| Phosphatase CRISPR Library | A42267 | A32168 | 288 | |
| Cancer Biology CRISPR Library | A42268 | A32169 | 510 | |
| Epigenetics CRISPR Library | A42269 | A32170 | 396 | |
| Ubiquitin CRISPR Library | A42270 | A32171 | 943 | |
| Cell Cycle CRISPR Library | A42271 | A32172 | 1444 | |
| Membrane Trafficking CRISPR Library | A42272 | A32173 | 141 | |
| Transcription Factor CRISPR Library | A42273 | A32174 | 1817 | |
| Nuclear Hormone Receptor CRISPR Library | A42274 | A32175 | 47 | |
| Apoptosis CRISPR Library | A42275 | A32176 | 904 | |
| Drug Transporter CRISPR Library | A42276 | A32177 | 98 | |
| Ion Channel CRISPR Library | A42277 | A32178 | 328 | |
| Cell Surface CRISPR Library | A42278 | A32179 | 778 | |
| Protease CRISPR Library | A42279 | A32180 | 475 | |
| Tumor Suppressor CRISPR Library | A42280 | A32181 | 716 | |
| DNA Damage Response CRISPR Library | A42281 | A32182 | 561 | |
| GPCR CRISPR Library | A42282 | A32183 | 446 | |
| Druggable CRISPR Library | Inquire | A32184 | 10,128 | |
| Whole Genome CRISPR Library | Inquire | A32185 | 18,453 | |
| LentiPool Negative Control CRISPR Library | N/A | N/A | N/A | |
| Custom CRISPR Library | Inquire | Inquire | Custom |
Resources
Publications
Press release
User Guides
For Research Use Only. Not for use in diagnostic procedures.